Related Experiment Video
Updated: May 11, 2026

13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination
Joseph E Tota1, Agnihotram V Ramanakumar, Mengzhu Jiang
1Division of Cancer Epidemiology, Department of Oncology, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
American Journal of Epidemiology
|May 11, 2013
Summary
Human papillomavirus (HPV) vaccines may alter the prevalence of oncogenic HPV types. This study explores "type replacement" and evaluates methods to assess HPV type competition and diagnostic artifacts post-vaccination.
Area of Science:
- Epidemiology
- Virology
- Public Health
Background:
- Two vaccines target human papillomavirus (HPV) genotypes causing ~70% of cervical cancer.
- Vaccination may impact the distribution of other oncogenic HPV types due to potential competition.
Purpose of the Study:
- To discuss the issue of HPV "type replacement" following vaccination.
- To present epidemiologic approaches for evaluating HPV type competition.
- To address diagnostic artifacts that may affect HPV type detection.
Main Methods:
- Comparing observed HPV coinfection frequencies with expected frequencies under independence.
- Utilizing hierarchical logistic regression models for vaccine-targeted HPV types.
- Employing Kaplan-Meier curves and Cox models to analyze HPV type acquisition and clearance dynamics.
Main Results:
- Discusses the theoretical basis for HPV type replacement due to ecological competition.
- Outlines statistical and epidemiological methods for assessing type replacement.
- Highlights potential diagnostic challenges in detecting low-prevalence HPV types post-vaccination.
Conclusions:
- Vaccination against specific HPV types may lead to shifts in the prevalence of non-targeted oncogenic HPV types.
- Epidemiologic studies are crucial for monitoring HPV type distribution changes.
- Awareness of diagnostic limitations is necessary for accurate HPV surveillance post-vaccination.
Related Concept Videos
Vaccinations
Overview
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
